Company Valuation: Dolby Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: September 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 9,375 6,589 7,494 7,231 6,938 5,844 - -
Change - -29.72% 13.74% -3.51% -4.05% -15.77% - -
Enterprise Value (EV) 8,103 5,772 7,494 7,231 6,938 5,844 5,844 5,844
Change - -28.77% 29.85% -3.51% -4.05% -15.77% 0% 0%
P/E 31.1x 37.3x 38.2x 28.2x 27.6x 20.2x 17.6x 16.9x
PBR 3.6x 2.88x - - 2.65x 2.23x - -
PEG - -1x 2.9x 0.9x -10.61x 1.1x 1.2x 4.13x
Capitalization / Revenue 7.32x 5.26x 5.77x 5.68x 5.14x 4.12x 3.98x 3.81x
EV / Revenue 0x 0x 0x 0x 0x 4.12x 3.98x 3.81x
EV / EBITDA 0x 0x 0x 0x 0x 10.7x 10.3x 9.41x
EV / EBIT 0x 0x 0x 0x 0x 19.3x 17.2x 14.4x
EV / FCF 0x 0x 0x 0x 0x 14.1x 11.9x 10.8x
FCF Yield 4.2% 4.11% 4.49% 4.11% 6.28% 7.08% 8.43% 9.23%
Dividend per Share 2 0.91 1.02 1.11 - 1.32 - - -
Rate of return 0.98% 1.51% 1.42% - 1.82% - - -
EPS 2 2.97 1.81 2.05 2.69 2.62 3.092 3.545 3.69
Distribution rate 30.6% 56.4% 54.1% - 50.4% - - -
Net sales 1 1,281 1,254 1,300 1,274 1,349 1,420 1,467 1,535
EBITDA 1 550.2 420.6 463.9 460.1 496.3 547.1 569.6 621.2
EBIT 1 344.4 206.6 215.8 258.3 265 302.5 339.2 404.7
Net income 1 310.2 184.1 200.7 261.8 255 255.7 292.3 349
Net Debt -1,272 -817.6 - - - - - -
Reference price 2 92.47 67.46 78.36 75.84 72.39 62.39 62.39 62.39
Nbr of stocks (in thousands) 101,387 97,677 95,641 95,348 95,844 93,669 - -
Announcement Date 16/11/21 17/11/22 16/11/23 19/11/24 18/11/25 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
20.17x - - - 5.84B
-428.86x8.24x30.78x-.--% 29.69B
162.99x0.96x13.25x-.--% 7.86B
60.3x1.75x10.43x-.--% 3.7B
-45.54x - - - 1.54B
22.04x - - - 444M
132.18x4.64x15x - 383M
Average -10.96x 3.90x 17.36x 0% 7.07B
Weighted average by Cap. -224.84x 6.26x 25.51x 0%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. DLB Stock
  4. Valuation Dolby Laboratories, Inc.